0000000001070059

AUTHOR

Vuk P. Jovanovic

showing 2 related works from this author

Not all women diagnosed with PCOS share the same cardiovascular risk profiles

2009

Although definitive and confirmatory data are lacking, women with polycystic ovary syndrome (PCOS) are considered to be at increased risk for cardiovascular and metabolic disease. In recent years, the diagnosis of PCOS has broadened considerably to result in several phenotypes. Here we review the evidence for cardiovascular and metabolic risks in PCOS in the classic disorder and the various phenotypes. We conclude that not all women with PCOS should be considered as being similar in terms of cardiovascular risk profiles.

medicine.medical_specialtyPCOS cardiovascular risk hyperandrogenism insulin resistance metabolic syndrome lipid profileendocrine system diseasesRisk profileSettore MED/13 - EndocrinologiaMetabolic DiseasesRisk FactorsInternal medicinemedicineHumansCystMetabolic diseaseVascular diseasebusiness.industrynutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryObesityfemale genital diseases and pregnancy complicationsPhenotypeEndocrinologyIncreased riskReproductive MedicineCardiovascular DiseasesMetabolomeFemaleMetabolic syndromeHyperandrogenismbusinessPolycystic Ovary SyndromeFertility and Sterility
researchProduct

Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dl…

2013

Background In-situ hybridisation studies demonstrate that Notch receptors and ligands are expressed in granulosa cells (GCs) and in the theca layer vasculature of growing follicles. Notch signaling involves cell-to-cell interaction mediated by transmembrane receptors and ligands. This signaling pathway may represent a novel intraovarian regulator of gonadotropin-dependent follicular development to the preovulatory stage. We hypothesized that blocking Notch pathways would disrupt follicular maturation in the mouse ovary. Methods Hypophysectomized CD21 female mice were administered pregnant mare serum gonadotropin (PMSG) for 3 days to stimulate follicular development. In one experiment, a pan…

Gonadotropins EquineYW152FMiceEndocrinologyOvarian FolliclePregnancyFollicular phaseReceptor Notch2Receptor Notch1Receptor Notch4Receptor Notch3education.field_of_studyReceptors NotchIntracellular Signaling Peptides and ProteinsObstetrics and GynecologyImmunohistochemistryFolliculogenesisObstetricsmedicine.anatomical_structureNotch proteinsThecaTheca Cellscardiovascular systemFemaleJaggedFolliculogenesisSignal Transductionendocrine systemmedicine.medical_specialtyNotchGamma-secretase inhibitorNotch signaling pathwayDll4BiologyProto-Oncogene ProteinsInternal medicineGeneticsmedicineAnimalsHorsesOvarian follicleAntibodies BlockingeducationGranulosa CellsDelta-like ligand 4ResearchOvaryEndothelial CellsMembrane ProteinsMuscle SmoothEstradiol secretionEndocrinologyReproductive MedicineGynecologyFOS: Biological sciencesDevelopmental BiologyReproductive Biology and Endocrinology
researchProduct